Shree Pacetronix (527005.BO) Stock Price

Shree Pacetronix Ltd. generates revenue through the sale of implantable cardiac pacemakers and related medical devices. The company's product portfolio includes multi-programmable pacemakers such as Ventralite 940 +/ Tiranga, Pinnacle 8820, and Tiranga 302, as well as rate responsive pacemakers like Charak DDDR and Pinnacle-R SSIR + Model 297. Bivent pacemakers such as Trinity R and external pacemakers including Indus I SSB and Zeus-1 are also sold. Additional products consist of pacing system analyzers, physician corners, and pacing leads like temporary leads, Screw-in lead P12 Model 3844 VB/ 3744VB, IS1 Bipolar Lead 3851 VB, and Atrial J Bipolar Lead 3851 VB. The company serves the Life Saving Devices segment with a focus on India and the Rest of the World, targeting healthcare providers and medical institutions requiring cardiac pacemaker solutions. Shree Pacetronix Ltd. operates under the Life Saving Devices segment, offering specialized medical equipment for cardiac care. Its subsidiary Shree Coratomic Limited supports the company's operations. The primary buyers are healthcare facilities and medical institutions in India and international markets, purchasing pacemakers and associated devices for patient treatment. Products are distributed through medical supply channels to hospitals and clinics specializing in cardiology. The firm's revenue streams are derived from the direct sale of its branded medical devices. Key products include the Ventralite 940 +/ Tiranga, Pinnacle 8820, Tiranga 302, Charak DDDR, Pinnacle-R SSIR + Model 297, Trinity R, Indus I SSB, Zeus-1, Smart-E programmer, and various pacing leads. These products are sold to healthcare providers globally, with significant market presence in India and the Rest of the World. The company's business model centers on providing essential cardiac care equipment through its comprehensive product range.